Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Alison Pierson"'
Autor:
Romain Darrigrand, Alison Pierson, Marine Rouillon, Dolor Renko, Mathilde Boulpicante, David Bouyssié, Emmanuelle Mouton-Barbosa, Julien Marcoux, Camille Garcia, Michael Ghosh, Mouad Alami, Sébastien Apcher
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-14 (2021)
Darrigrand, Pierson et al. study the effect of mRNA splicing inhibitors on the generation of the MHC class I ligands. They developed a derivative of the spliceosome inhibitor isoginkgetin which is less toxic and more effective at enhancing antigen pr
Externí odkaz:
https://doaj.org/article/1c8392da73b6409daf3965425089b16d
Autor:
Mathilde Boulpicante, Romain Darrigrand, Alison Pierson, Valérie Salgues, Marine Rouillon, Benoit Gaudineau, Mehdi Khaled, Angela Cattaneo, Angela Bachi, Paolo Cascio, Sébastien Apcher
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
The success of CD8+ T cell-based cancer immunotherapy emphasizes the importance of understanding the mechanisms of generation of MHC-I peptide ligands and the possible pathways of tumor cell escape from immunosurveillance. Recently, we showed that pe
Externí odkaz:
https://doaj.org/article/a076e0934c1f4b449dbf30d655faec53
Autor:
Dolor Renko, Romain Darrigrand, Marine Rouillon, Mouad Alami, Mathilde Boulpicante, Julien Marcoux, Michael Ghosh, Camille Garcia, Alison Pierson, David Bouyssié, Sébastien Apcher, Emmanuelle Mouton-Barbosa
Publikováno v:
Communications Biology
Communications Biology, Nature Publishing Group, 2021, 4 (1), ⟨10.1038/s42003-021-01801-2⟩
Communications Biology, Vol 4, Iss 1, Pp 1-14 (2021)
Communications Biology, Nature Publishing Group, 2021, 4 (1), ⟨10.1038/s42003-021-01801-2⟩
Communications Biology, Vol 4, Iss 1, Pp 1-14 (2021)
The success of cancer immunotherapy relies on the induction of an immunoprotective response targeting tumor antigens (TAs) presented on MHC-I molecules. We demonstrated that the splicing inhibitor isoginkgetin and its water-soluble and non-toxic deri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8b7ed2073a3b29ecd025c65e319e909
https://doi.org/10.1038/s42003-021-01801-2
https://doi.org/10.1038/s42003-021-01801-2
Autor:
Angela Bachi, Alison Pierson, Romain Darrigrand, Angela Cattaneo, Mehdi Khaled, Paolo Cascio, Mathilde Boulpicante, Sébastien Apcher, Benoit Gaudineau, Valerie Salgues
The success of CD8+ T cell based cancer immunotherapy emphasizes the importance of understanding the mechanisms of generation of MHC-I peptide ligands and possible pathways of tumor cell escape from immunosurveillance. Recently, we showed that peptid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64446bab283cdb5fa7fc709616f7e0f5
https://doi.org/10.1101/511873
https://doi.org/10.1101/511873
Autor:
Mathilde Boulpicante, Camille Garcia, Marie-Charlotte Laiguillon, Marine Rouillon, Romain Darrigrand, Camille Lobry, Michael Ghosh, Zafiarisoa Dolor Renko, Alison Pierson, Sébastien Apcher, Mouad Alami
The success of cancer immunotherapy relies on the induction of an immunoprotective response targeting tumor antigens (TAs) presented by tumor cells on MHC class I molecules. Alternative translation events emerged as a rich source of TAs and generate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d4d6a351cac1ab7c3911a67849b7d10
https://doi.org/10.1101/512681
https://doi.org/10.1101/512681